All funds

DNB Health Care A

Equity fund

1 year

Region

USA

Largest region

Medium

Risk

Annual costs

Morningstar

 

Partial 

Sustainability

Development

Last 5 years
( ann.)

Description

  • DNB Health Care er et aktivt forvaltet aksjefond som hovedsakelig investerer i aksjer i selskaper innenfor helsetjenester, legemiddel, medisinsk utstyr, bioteknologi og annen beslektet virksomhet, notert på børser og regulerte markeder over hele verden. USA er en vesentlig del av helsemarkedet og fondet vil normalt ha en betydelig andel av investeringene her.
    Read more

Investment horizon

  • DNB Health Care A is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.

Characteristics

  • Minimum amount
  • Sharpe 3 years
  • Price/NAV

    24 Jun 2025

  • Start date
    05 Jun 2000
  • ISIN
    NO0010337579

Risk

  • Medium (4 of 7)

  • High risk (5-7) shows that the fund can give a high return, but that your money can fluctuate widely in value.

Morningstar rating

  • The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.

Sustainability

  • Sustainability
    Partial
     

    A fund that, in addition to other considerations, promotes environmental and social aspects through its investment strategy. They do not have sustainable investments as the main objective.
    The funds are subject to disclosure requirements set out in Article 8 of the SFDR (Sustainable Finance Disclosure Regulation)

    Read more about sustainability classifications

Costs

  • Ongoing costs

    Includes management fees of 0,85 %

  • Platform fee
  • Kickback fee
  • Annual running costs
  • Performance-based fee

  • Any transaction costs to the manager are not included in the cost overview. These are stated under cost details on the summary page before you purchase the fund. Costs for any currency exchanges are not included.

Allocation

  • Stocks 99%
    Interest 1%

Portfolio

Shows the fund's largest investments.

  • Eli Lilly and Co
    8.0%
  • Roche Holding AG
    6.3%
  • AstraZeneca PLC
    6.2%
  • Novo Nordisk AS Class B
    5.8%
  • Johnson & Johnson
    5.7%
  • Lonza Group Ltd
    4.0%
  • Sanofi SA
    3.4%
  • UnitedHealth Group Inc
    3.1%
  • Thermo Fisher Scientific Inc
    3.0%
  • DexCom Inc
    2.8%